1. Abreu, R. de S., Penalva, L. O., Marcotte, E. M. & Vogel, C. Global signatures of protein and mRNA expression levels. Mol Biosyst 5, 1512–1526 (2009).
2. de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M. & Vogel, C. Global signatures of protein and mRNA expression levels. Mol Biosyst 5, 1512–1526 (2009).
3. Maier, T., Güell, M. & Serrano, L. Correlation of mRNA and protein in complex biological samples. FEBS Lett 583, 3966–3973 (2009).
4. Buccitelli, C. & Selbach, M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet 21, 630–644 (2020).
5. Emmott, E., Jovanovic, M. & Slavov, N. Ribosome Stoichiometry: From Form to Function. Trends in Biochemical Sciences 44, 95–109 (2019).
6. Tahmasebi, S., Khoutorsky, A., Mathews, M. B. & Sonenberg, N. Translation deregulation in human disease. Nat Rev Mol Cell Biol 19, 791–807 (2018).
7. Teixeira, F. K. & Lehmann, R. Translational Control during Developmental Transitions. Cold Spring Harb Perspect Biol 11, a032987 (2019).
8. Zhao, B. S., Roundtree, I. A. & He, C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol 18, 31–42 (2017).
9. Jansen, M., de Moor, C. H., Sussenbach, J. S. & van den Brande, J. L. Translational control of gene expression. Pediatr Res 37, 681–686 (1995).
10. Topisirovic, I. & Sonenberg, N. mRNA translation and energy metabolism in cancer: the role of the MAPK and mTORC1 pathways. Cold Spring Harb Symp Quant Biol 76, 355– 367 (2011).
11. Kozak, M. Influence of mRNA secondary structure on binding and migration of 40S ribosomal subunits. Cell 19, 79–90 (1980).
12. Pestova, T. V. & Kolupaeva, V. G. The roles of individual eukaryotic translation initiation factors in ribosomal scanning and initiation codon selection. Genes Dev. 16, 2906–2922 (2002).
13. Macejak, D. G. & Sarnow, P. Internal initiation of translation mediated by the 5’ leader of a cellular mRNA. Nature 353, 90–94 (1991).
14. Beretta, L., Gingras, A. C., Svitkin, Y. V., Hall, M. N. & Sonenberg, N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 15, 658–664 (1996).
15. Winter, J. N., Jefferson, L. S. & Kimball, S. R. ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling. Am J Physiol Cell Physiol 300, C1172-1180 (2011).
16. Chung, J., Grammer, T. C., Lemon, K. P., Kazlauskas, A. & Blenis, J. PDGF- and insulin- dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370, 71–75 (1994).
17. Kim, D.-H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163–175 (2002).
18. Kandel, E. S. & Hay, N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253, 210–229 (1999).
19. Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K.-L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4, 648–657 (2002).
20. Castro, A. F., Rebhun, J. F., Clark, G. J. & Quilliam, L. A. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation- dependent manner. J Biol Chem 278, 32493–32496 (2003).
21. Zhang, Y. et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5, 578–581 (2003).
22. Li, Y., Inoki, K., Vacratsis, P. & Guan, K.-L. The p38 and MK2 Kinase Cascade Phosphorylates Tuberin, the Tuberous Sclerosis 2 Gene Product, and Enhances Its Interaction with 14-3-3 *. Journal of Biological Chemistry 278, 13663–13671 (2003).
23. Holz, M. K., Ballif, B. A., Gygi, S. P. & Blenis, J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123, 569–580 (2005).
24. Roux, P. P. et al. RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 282, 14056–14064 (2007).
25. Yang, H.-S. et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23, 26–37 (2003).
26. Dorrello, N. V. et al. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314, 467–471 (2006).
27. Wang, X. et al. Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase. EMBO J 20, 4370–4379 (2001).
28. Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H. & Sabatini, D. M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci U S A 95, 1432–1437 (1998).
29. Ueda, T., Watanabe-Fukunaga, R., Fukuyama, H., Nagata, S. & Fukunaga, R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 24, 6539–6549 (2004).
30. Zhu, J. & Thompson, C. B. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol 20, 436–450 (2019).
31. Hershey, J. W. B. Regulation of protein synthesis and the role of eIF3 in cancer. Braz J Med Biol Res 43, 920–930 (2010).
32. Bhat, M. et al. Targeting the translation machinery in cancer. Nat Rev Drug Discov 14, 261–278 (2015).
33. de la Parra, C., Walters, B. A., Geter, P. & Schneider, R. J. Translation initiation factors and their relevance in cancer. Current Opinion in Genetics & Development 48, 82–88 (2018).
34. Truitt, M. L. & Ruggero, D. New frontiers in translational control of the cancer genome. Nat Rev Cancer 16, 288–304 (2016).
35. Boroughs, L. K. & DeBerardinis, R. J. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol 17, 351–359 (2015).
36. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science 324, 1029–1033 (2009).
37. Ussowicz, M. et al. Analysis of the rRNA methylation complex components in pediatric B-cell precursor acute lymphoblastic leukemia: A pilot study. Adv Clin Exp Med 29, 107– 113 (2020).
38. Robichaud, N. et al. Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3. Oncogene 34, 2032–2042 (2015).
39. Ruggero, D. Translational control in cancer etiology. Cold Spring Harb Perspect Biol 5, a012336 (2013).
40. Silvera, D., Formenti, S. C. & Schneider, R. J. Translational control in cancer. Nat Rev Cancer 10, 254–266 (2010).
41. Martineau, Y. et al. Pancreatic tumours escape from translational control through 4E-BP1 loss. Oncogene 33, 1367–1374 (2014).
42. Zhang, L., Pan, X. & Hershey, J. W. B. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 282, 5790–5800 (2007).
43. Tian, T., Li, X. & Zhang, J. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy. Int J Mol Sci 20, 755 (2019).
44. Xie, J., Wang, X. & Proud, C. G. mTOR inhibitors in cancer therapy. F1000Res 5, F1000 Faculty Rev-2078 (2016).
45. Zou, Z., Tao, T., Li, H. & Zhu, X. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell & Bioscience 10, 31 (2020).
46. Hua, H. et al. Targeting mTOR for cancer therapy. J Hematol Oncol 12, 71 (2019).
47. Bozulic, L. & Hemmings, B. A. PIKKing on PKB: regulation of PKB activity by phosphorylation. Curr Opin Cell Biol 21, 256–261 (2009).
48. Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P. & Guan, K.-L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 10, 935–945 (2008).
49. PARK, E. et al. NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations. Int J Oncol 40, 1259– 1266 (2011).
50. Rastogi, R. et al. Rapamycin Induces Mitogen-activated Protein (MAP) Kinase Phosphatase-1 (MKP-1) Expression through Activation of Protein Kinase B and Mitogen- activated Protein Kinase Kinase Pathways. J Biol Chem 288, 33966–33977 (2013).
51. Wang, X. et al. Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors’ anticancer efficacy. Cancer Biol Ther 7, 1952–1958 (2008).
52. Cantoni, G. L. S-Adenosylmethionine; a new intermediate formed enzymatically from L- methionine and adenosinetriphosphate. J Biol Chem 204, 403–416 (1953).
53. Sakata, S. F. et al. Effect of Fasting on Methionine Adenosyltransferase Expression and the Methionine Cycle in the Mouse Liver. Journal of Nutritional Science and Vitaminology 51, 118–123 (2005).
54. Sakata, S. F., Shelly, L. L., Ruppert, S., Schutz, G. & Chou, J. Y. Cloning and expression of murine S-adenosylmethionine synthetase. J Biol Chem 268, 13978–13986 (1993).
55. Halim, A. B., LeGros, L., Chamberlin, M. E., Geller, A. & Kotb, M. Regulation of the human MAT2A gene encoding the catalytic alpha 2 subunit of methionine adenosyltransferase, MAT II: gene organization, promoter characterization, and identification of a site in the proximal promoter that is essential for its activity. J Biol Chem 276, 9784–9791 (2001).
56. Kotb, M. et al. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet 13, 51–52 (1997).
57. LeGros, L., Halim, A. B., Chamberlin, M. E., Geller, A. & Kotb, M. Regulation of the human MAT2B gene encoding the regulatory beta subunit of methionine adenosyltransferase, MAT II. J Biol Chem 276, 24918–24924 (2001).
58. Murray, B. et al. Structure and function study of the complex that synthesizes S- adenosylmethionine. IUCrJ 1, 240–249 (2014).
59. Kaiser, P. Methionine Dependence of Cancer. Biomolecules 10, 568 (2020).
60. Booher, K., Lin, D.-W., Borrego, S. L. & Kaiser, P. Downregulation of Cdc6 and pre- replication complexes in response to methionine stress in breast cancer cells. Cell Cycle 11, 4414–4423 (2012).
61. Lin, D.-W., Chung, B. P. & Kaiser, P. S-adenosylmethionine limitation induces p38 mitogen-activated protein kinase and triggers cell cycle arrest in G1. J Cell Sci 127, 50– 59 (2014).
62. Cai, J., Sun, W. M., Hwang, J. J., Stain, S. C. & Lu, S. C. Changes in S- adenosylmethionine synthetase in human liver cancer: molecular characterization and significance. Hepatology 24, 1090–1097 (1996).
63. Huang, Z.-Z., Mao, Z., Cai, J. & Lu, S. C. Changes in methionine adenosyltransferase during liver regeneration in the rat. American Journal of Physiology-Gastrointestinal and Liver Physiology 275, G14–G21 (1998).
64. Frau, M., Feo, F. & Pascale, R. M. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. Journal of Hepatology 59, 830–841 (2013).
65. Liu, T. et al. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer. Gastroenterology 155, 557-571.e14 (2018).
66. Chen, H. et al. Circular RNA hsa_circ_0007364 increases cervical cancer progression through activating methionine adenosyltransferase II alpha (MAT2A) expression by restraining microRNA-101-5p. Bioengineered 11, 1269–1279 (2020).
67. Tomasi, M. L. et al. Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer. Exp Cell Res 319, 1902–1911 (2013).
68. Phuong, N. T. T. et al. Induction of methionine adenosyltransferase 2A in tamoxifen- resistant breast cancer cells. Oncotarget 7, 13902–13916 (2016).
69. Villa, E. et al. mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA- dependent control of protein synthesis. Molecular Cell 81, 2076-2093.e9 (2021).
70. Gu, X. et al. SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science 358, 813–818 (2017).
71. Ringeard, M., Marchand, V., Decroly, E., Motorin, Y. & Bennasser, Y. FTSJ3 is an RNA 2′-O-methyltransferase recruited by HIV to avoid innate immune sensing. Nature 565, 500–504 (2019).
72. Morello, L. G. et al. The Human Nucleolar Protein FTSJ3 Associates with NIP7 and Functions in Pre-rRNA Processing. PLOS ONE 6, e29174 (2011).
73. Ishiguro, K., Arai, T. & Suzuki, T. Depletion of S-adenosylmethionine impacts on ribosome biogenesis through hypomodification of a single rRNA methylation. Nucleic Acids Research 47, 4226–4239 (2019).
74. Polevoda, B. & Sherman, F. Methylation of proteins involved in translation. Molecular Microbiology 65, 590–606 (2007).
75. Malecki, J. et al. The novel lysine specific methyltransferase METTL21B affects mRNA translation through inducible and dynamic methylation of Lys-165 in human eukaryotic elongation factor 1 alpha (eEF1A). Nucleic Acids Res 45, 4370–4389 (2017).
76. Liu, S. et al. METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. Cell 176, 491-504.e21 (2019).
77. Katoh, Y. et al. Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein. Mol Cell 41, 554–566 (2011).
78. Boer, E. de et al. Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice. Proceedings of the National Academy of Sciences of the United States of America (2003) doi:10.1073/pnas.1332608100.
79. Shechter, D., Dormann, H. L., Allis, C. D. & Hake, S. B. Extraction, purification and analysis of histones. Nat Protoc 2, 1445–1457 (2007).
80. Shima, H. et al. S-Adenosylmethionine Synthesis Is Regulated by Selective N6- Adenosine Methylation and mRNA Degradation Involving METTL16 and YTHDC1. Cell Reports 21, 3354–3363 (2017).
81. Schmidt, E. K., Clavarino, G., Ceppi, M. & Pierre, P. SUnSET, a nonradioactive method to monitor protein synthesis. Nature methods 6, 275–277 (2009).
82. Kera, Y. et al. Methionine Adenosyltransferase II-dependent Histone H3K9 Methylation at the COX-2 Gene Locus. J Biol Chem 288, 13592–13601 (2013).
83. Frazier, M. L., Mars, W., Florine, D. L., Montagna, R. A. & Saunders, G. F. Efficient extraction of RNA from mammalian tissue. Mol Cell Biochem 56, 113–122 (1983).
84. Corsini, N. S. et al. Coordinated Control of mRNA and rRNA Processing Controls Embryonic Stem Cell Pluripotency and Differentiation. Cell Stem Cell 22, 543-558.e12 (2018).
85. Matsuo, Y. et al. Ubiquitination of stalled ribosome triggers ribosome-associated quality control. Nat Commun 8, 159 (2017).
86. Ochiai, K. et al. Protocol for in vitro BCR-mediated plasma cell differentiation and purification of chromatin-associated proteins. STAR Protocols 2, 100633 (2021).
87. Tanaka, H. et al. Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3. J Biol Chem 291, 6316–6330 (2016).
88. Cao, X.-J., Zee, B. M. & Garcia, B. A. Heavy methyl-SILAC labeling coupled with liquid chromatography and high-resolution mass spectrometry to study the dynamics of site- specific histone methylation. Methods Mol Biol 977, 299–313 (2013).
89. Musiani, D. et al. Proteomics profiling of arginine methylation defines PRMT5 substrate specificity. Sci Signal 12, eaat8388 (2019).
90. Ong, S.-E., Mittler, G. & Mann, M. Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. Nature Methods 1, 119–126 (2004).
91. Azzam, M. E. & Algranati, I. D. Mechanism of puromycin action: fate of ribosomes after release of nascent protein chains from polysomes. Proc Natl Acad Sci U S A 70, 3866– 3869 (1973).
92. Shafqat, N. et al. Insight into S-adenosylmethionine biosynthesis from the crystal structures of the human methionine adenosyltransferase catalytic and regulatory subunits. Biochem J 452, 27–36 (2013).
93. Jani, T. S. et al. Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells. Cell Res 19, 358–369 (2009).
94. Sufrin, J. R., Coulter, A. W. & Talalay, P. Structural and conformational analogues of L- methionine as inhibitors of the enzymatic synthesis of S-adenosyl-L-methionine. IV. Further mono-, bi- and tricyclic amino acids. Mol Pharmacol 15, 661–677 (1979).
95. Gingras, A. C., Raught, B. & Sonenberg, N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68, 913–963 (1999).
96. Carracedo, A. et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118, 3065–3074 (2008).
97. Li, Y. et al. Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation. J Biol Chem 288, 13215–13224 (2013).
98. Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496–1501 (2008).
99. Monaco, P. L., Marcel, V., Diaz, J.-J. & Catez, F. 2’-O-Methylation of Ribosomal RNA: Towards an Epitranscriptomic Control of Translation? Biomolecules 8, E106 (2018).
100. Henras, A. K., Plisson-Chastang, C., O’Donohue, M.-F., Chakraborty, A. & Gleizes, P.-E. An overview of pre-ribosomal RNA processing in eukaryotes. Wiley Interdiscip Rev RNA 6, 225–242 (2015).
101. Figaro, S. et al. Trm112 is required for Bud23-mediated methylation of the 18S rRNA at position G1575. Mol Cell Biol 32, 2254–2267 (2012).
102. Shubina, M. Y., Musinova, Y. R. & Sheval, E. V. Nucleolar Methyltransferase Fibrillarin: Evolution of Structure and Functions. Biochemistry (Mosc) 81, 941–950 (2016).
103. Hamey, J. J. & Wilkins, M. R. Methylation of Elongation Factor 1A: Where, Who, and Why? Trends in Biochemical Sciences 43, 211–223 (2018).
104. Li, Z., Gonzalez, P. A., Sasvari, Z., Kinzy, T. G. & Nagy, P. D. Methylation of translation elongation factor 1A by the METTL10-like See1 methyltransferase facilitates tombusvirus replication in yeast and plants. Virology 448, 43–54 (2014).
105. Swiercz, R., Person, M. D. & Bedford, M. T. Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3). Biochem J 386, 85–91 (2005).
106. White, J. T. et al. Protein methylation and translation: Role of lysine modification on the function of yeast elongation factor 1A. Biochemistry 58, 4997–5010 (2019).
107. Davydova, E. et al. Identification and characterization of a novel evolutionarily conserved lysine-specific methyltransferase targeting eukaryotic translation elongation factor 2 (eEF2). J Biol Chem 289, 30499–30510 (2014).
108. Lu, S. C. & Mato, J. M. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev 92, 1515–1542 (2012).
109. Hoffman, R. M. Methionine dependence in cancer cells - a review. In Vitro 18, 421–428 (1982).
110. Mecham, J. O., Rowitch, D., Wallace, C. D., Stern, P. H. & Hoffman, R. M. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 117, 429–434 (1983).
111. Módis, K. et al. Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro. Nitric Oxide 41, 146–156 (2014).
112. Obata, F. et al. Nutritional Control of Stem Cell Division through S-Adenosylmethionine in Drosophila Intestine. Developmental Cell 44, 741-751.e3 (2018).
113. Saito, Y. et al. Effect of essential amino acids on enteroids: Methionine deprivation suppresses proliferation and affects differentiation in enteroid stem cells. Biochem Biophys Res Commun 488, 171–176 (2017).
114. Shiraki, N. et al. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Cell Metab 19, 780–794 (2014).
115. Lu, S. & Epner, D. E. Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr Cancer 38, 123–130 (2000).
116. Li, T. W. H. et al. Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice. Carcinogenesis 33, 427–435 (2012).
117. Zsigrai, S. et al. S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression. Cells 9, E1864 (2020).
118. Cave, D. D. et al. S-Adenosylmethionine-mediated apoptosis is potentiated by autophagy inhibition induced by chloroquine in human breast cancer cells. J Cell Physiol 233, 1370– 1383 (2018).
119. Yan, L. et al. S-Adenosylmethionine Affects Cell Cycle Pathways and Suppresses Proliferation in Liver Cells. J Cancer 10, 4368–4379 (2019).
120. Muranen, T. et al. Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix- Attached Cancer Cells. Cancer Cell 21, 227–239 (2012).
121. Zhao, C. et al. MAT2A promotes porcine adipogenesis by mediating H3K27me3 at Wnt10b locus and repressing Wnt/β-catenin signaling. Biochim Biophys Acta Mol Cell Biol Lipids 1863, 132–142 (2018).
122. Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496–1501 (2008).
123. Bhatt, A. P. et al. Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas. Blood 115, 4455–4463 (2010).
124. Shi, Y., Yan, H., Frost, P., Gera, J. & Lichtenstein, A. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin- like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade. Mol Cancer Ther 4, 1533–1540 (2005).
125. Dai, C.-L. et al. Inhibition of Protein Synthesis Alters Protein Degradation through Activation of Protein Kinase B (AKT). J Biol Chem 288, 23875–23883 (2013).
126. Zinck, R. et al. Protein synthesis inhibitors reveal differential regulation of mitogen- activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol Cell Biol 15, 4930–4938 (1995).
127. Mauer, J. et al. Reversible methylation of m6Am in the 5’ cap controls mRNA stability. Nature 541, 371–375 (2017).
128. Shearstone, J. R. et al. Global DNA demethylation during mouse erythropoiesis in vivo. Science 334, 799–802 (2011).
129. Wong, P. et al. Gene induction and repression during terminal erythropoiesis are mediated by distinct epigenetic changes. Blood 118, e128–e138 (2011).
130. Caboche, M. & Bachellerie, J. P. RNA methylation and control of eukaryotic RNA biosynthesis. Effects of cycloleucine, a specific inhibitor of methylation, on ribosomal RNA maturation. Eur J Biochem 74, 19–29 (1977).
131. Yi, Y. et al. A PRC2-independent function for EZH2 in regulating rRNA 2′-O methylation and IRES-dependent translation. Nat Cell Biol 23, 341–354 (2021).
132. Xiao, S. et al. Dimethylation of eEF1A at Lysine 55 Plays a Key Role in the Regulation of eEF1A2 on Malignant Cell Functions of Acute Myeloid Leukemia. Technol Cancer Res Treat 19, 1533033820914295 (2020).
133. Jakobsson, M. E. et al. The dual methyltransferase METTL13 targets N terminus and Lys55 of eEF1A and modulates codon-specific translation rates. Nat Commun 9, 3411 (2018).
134. Hua, X. et al. Effects of RNA Binding Proteins on the Prognosis and Malignant Progression in Prostate Cancer. Front Genet 11, 591667 (2020).
135. Wu, Y.-Q., Ju, C.-L., Wang, B.-J. & Wang, R.-G. PABPC1L depletion inhibits proliferation and migration via blockage of AKT pathway in human colorectal cancer cells. Oncol Lett 17, 3439–3445 (2019).
136. Rikova, K. et al. Abstract B197: Proteomic based analysis of ovarian cancer pathways. Mol Cancer Ther 12, B197–B197 (2013).
137. Wu, Z. et al. A Chemical Proteomics Approach for Global Analysis of Lysine Monomethylome Profiling. Mol Cell Proteomics 14, 329–339 (2015).
138. Craig, A. W. B., Haghighat, A., Yu, A. T. K. & Sonenberg, N. Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation. Nature 392, 520–523 (1998).
139. Gray, N. K., Coller, J. M., Dickson, K. S. & Wickens, M. Multiple portions of poly(A)- binding protein stimulate translation in vivo. EMBO J 19, 4723–4733 (2000).
140. Imataka, H., Gradi, A. & Sonenberg, N. A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)- dependent translation. EMBO J 17, 7480–7489 (1998).
141. Derry, M. C., Yanagiya, A., Martineau, Y. & Sonenberg, N. Regulation of poly(A)- binding protein through PABP-interacting proteins. Cold Spring Harb Symp Quant Biol 71, 537–543 (2006).
142. Jackson, R. J., Hellen, C. U. T. & Pestova, T. V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11, 113–127 (2010).
143. Endres, L. et al. 2’-O-ribose methylation of transfer RNA promotes recovery from oxidative stress in Saccharomyces cerevisiae. PLoS One 15, e0229103 (2020).
144. Liu, F. et al. ALKBH1-Mediated tRNA Demethylation Regulates Translation. Cell 167, 816-828.e16 (2016).
145. Tuorto, F. et al. RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. Nat Struct Mol Biol 19, 900–905 (2012).
146. Dumont, F. J. et al. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma. Cell Immunol 163, 70–79 (1995).
147. Lorenz, M. C. & Heitman, J. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J Biol Chem 270, 27531–27537 (1995).
148. Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098–1101 (2005).
149. Tamburini, J. et al. Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways. Blood 111, 379–382 (2008).
150. Dilling, M. B. et al. 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin. J Biol Chem 277, 13907–13917 (2002).
151. Kaplan, B., Qazi, Y. & Wellen, J. R. Strategies for the management of adverse events associated with mTOR inhibitors. Transplant Rev (Orlando) 28, 126–133 (2014).
論文の公開元へ
